Anzeige
Mehr »
Mittwoch, 30.07.2025 - Börsentäglich über 12.000 News
Geheime Millionen-Käufe in Bitcoin & Altcoins - ohne Wallet, ohne Risiko? Jetzt wird's spannend
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3ERJP | ISIN: US00688A2050 | Ticker-Symbol:
NASDAQ
29.07.25 | 21:59
0,610 US-Dollar
0,00 % 0,000
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
ADIAL PHARMACEUTICALS INC Chart 1 Jahr
5-Tage-Chart
ADIAL PHARMACEUTICALS INC 5-Tage-Chart

Aktuelle News zur ADIAL PHARMACEUTICALS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
16.07.Adial Pharmaceuticals regains compliance with Nasdaq stockholders' equity listing requirement4
16.07.Adial Pharmaceuticals, Inc: Adial Pharmaceuticals Regains Compliance with Nasdaq Stockholders' Equity Listing Requirement172GLEN ALLEN, Va., July 16, 2025 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) ("Adial" or the "Company"), a clinical-stage biopharmaceutical company focused on developing therapies...
► Artikel lesen
10.07.ADIAL PHARMACEUTICALS, INC. - 8-K, Current Report3
09.07.Adial Pharmaceuticals files patent update for alcohol disorder treatment1
ADIAL PHARMACEUTICALS Aktie jetzt für 0€ handeln
09.07.Adial Pharmaceuticals, Inc: Adial Pharmaceuticals Files PCT Patent Application to Protect Core Assets and Extend IP Exclusivity on Core Technology to at least 2045144GLEN ALLEN, Va., July 09, 2025 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) ("Adial" or the "Company"), a clinical-stage biopharmaceutical company focused on developing therapies...
► Artikel lesen
25.06.Adial signs manufacturing deals for alcohol disorder drug trials9
25.06.Adial Pharmaceuticals, Inc: Adial Pharmaceuticals Secures U.S.-Based Manufacturing Through Agreements with Cambrex and Thermo Fisher Scientific for Drug Substance and Drug Product Supply477Scope of Agreement with Cambrex to Provide Ondansetron HCL Drug Substance Under FDA Approved Drug Master File Scope Of Agreement With Thermo Fisher to Provide Manufacturing Services Including Demonstration...
► Artikel lesen
18.06.Adial Pharmaceuticals Prices $3.6 Mln Public Offering With Accompanying Warrants2
17.06.Adial Pharmaceuticals announces pricing of $3.6M public offering1
16.06.ADIAL PHARMACEUTICALS, INC. - 8-K, Current Report1
13.06.ADIAL PHARMACEUTICALS, INC. - S-1/A, General form for registration of securities1
11.06.Adial Pharmaceuticals macht Fortschritte bei Phase-3-Studiendesign für Alkoholsuchtmittel5
11.06.EXCLUSIVE: Adial Pharmaceuticals Lead Candidate For Alcohol Use Disorder Advances Toward Phase 3 Trial3
06.06.ADIAL PHARMACEUTICALS, INC. - S-1, General form for registration of securities3
30.05.Adial Pharmaceuticals files to register resale of 6.7M shares from warrant conversions2
30.05.ADIAL PHARMACEUTICALS, INC. - 8-K, Current Report1
15.05.Adial Pharmaceuticals reports Q1 results1
15.05.Adial Pharmaceuticals, Inc: Adial Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Business Update311GLEN ALLEN, Va., May 15, 2025 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) ("Adial" or the "Company"), a clinical-stage biopharmaceutical company focused on developing therapies...
► Artikel lesen
15.05.ADIAL PHARMACEUTICALS, INC. - 8-K, Current Report1
14.05.ADIAL PHARMACEUTICALS, INC. - 10-Q, Quarterly Report2
Weiter >>
56 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1